Pharma News, Research & Solutions CSR News

EndoChoice & 3 Keys to Growth: People. Products. Logistics.

Blog

One cool thing about working at UPS is the chance to learn about the many different types of companies we serve, and how their supply chains factor into their success. Healthcare companies are some of the most interesting: they make products that patients’ lives may literally depend on, and their supply chain needs can be quite specialized and complex. It can be pretty radical stuff!

Novo Nordisk Partners with Ministry of Health to Prevent Diabetes

Novo Nordisk and the Malaysian Ministry of Health are taking steps to prevent diabetes with a partnership encouraging young couples to adopt healthier habits - before they begin having children.
Press Release

November 14, 2012 /3BL Media/ - Today, Novo Nordisk entered into a public private partnership with the Malaysian Ministry of Health to prevent diabetes through a health promotion programme targeting young couples. The Jom Mama programme builds on research showing that women entering pregnancy overweight or obese increases the risk of developing non-communicable diseases, including type 2 diabetes, in both mother and child in later years of life.

The Logistics of Saving Lives: Keeping Cool Through a Challenging Delivery

Blog

Back in April, Walgreens donated more than 375,000 doses of flu vaccine to the Laos People’s Democratic Republic (Laos), when their flu season was just getting ready to begin. They wanted to make a difference in thousands of lives by bringing good health to a population in need. Walgreen’s faced an enormous logistical challenge to safely transport the vaccines from Louisville, Kentucky, to Southeast Asia.

Read more blog posts on the upside blog.

Berkery Noyes Says M&A Activity in Healthcare Up 20% for 2012; Healthways Study Links Well-Being to Job Performance; Goose Proofreader Ensures Accuracy in Pharma Data - Health Minute for October 18, 2012

Press Release

Berkery Noyes, an investment bank, has released its third quarter mergers and acquisitions trend report for the Healthcare/Pharma Information and Technology Industry. The report shows that M&A activity year-to-date improved 19 percent compared to the first three quarters of 2011. Market activity in the Healthcare Business Services segment rose 20 percent, while the number of transactions in the Medical Information segment more than doubled.

CVS Addresses High Cost of Drugs; United Healthcare, CBS EcoMedia Support New Vegetable Garden in Green Bay; GlaxoSmithKline Cancer Drug Trial has Successful Results - Health Minute for October 11, 2012

Press Release

A new survey by CVS Caremark of more than 2,400 of its retail pharmacists concludes that 62 percent of Americans believe the high cost of drugs is the biggest reason why as many as three out of four don’t take medications as prescribed. Non-adherence results in an estimated $300 billion a year in additional U.S. health care spending.

NORD Commends PhRMA for Adopting Principles for Interaction With Patient Organizations

Guidelines Emphasize Respecting the Values and Independence of Patient Organizations
Press Release

WASHINGTON, Sept. 28, 2012 / 3BL Media / PRNewswire-USNewswire/ -- The National Organization for Rare Disorders (NORD) today issued a statement commending the Pharmaceutical Research and Manufacturers of America (PhRMA) for adopting principles to guide the interaction between pharmaceutical companies and patient organizations.

(Logo: http://photos.prnewswire.com/prnh/20110719/DC37656LOGO-b)

GE Healthcare Launches Social Media Campaign for Cancer Prevention; United Healthcare Added to DJ Industrial Average; Aegerion supports First National FH Awareness Day - Health Minute for September 25, 2012

Press Release

GE Healthcare has launched a global competition on multiple social media platforms to raise public awareness about cancer prevention. Over the next few weeks, GE Healthcare’s “#GetFit” campaign will encourage people to share their own stories and information through  Twitter, Facebook, and Sina Weibo.

Pages

Subscribe to Pharma News, Research & Solutions